+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Interleukin"

Axial Spondyloarthritis (axSpA) - Pipeline Insight, 2025 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Chronic Spontaneous Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Interleukin 13 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 13 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 6 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 6 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-13 (IL-13) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-2 (IL-2) Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cryoprin-Associated Periodic Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
From
From
From
Loading Indicator

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases. In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more